 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 Triallyl phosphite |
| 2-((acryloyloxy)methyl)-2-methylpropane- |
| 1,3-Dimethyl 2,2-di-2-propen-1-ylpropane |
| Trimethylolethane trimethacrylate |
| Triallyl trimesate |
| triallyl 2-hydroxypropane-1,2,3-tricarbo |
| Diallyl 1,4-cyclohexanedicarboxylate |
| cyclohexane-1,4-diylbis(methylene) bis(2 |
| diallyl 2-hydroxysuccinate |
| 1,3-diallyl-5-propyl-1,3,5-triazinane-2, |
| dibutylstannanediyl bis(2-methylacrylate |
| 4,6-bis(allyloxy)-1,3,5-triazin-2(1H)-on |
| (1,3,5-triazine-2,4,6-triyl)tris(ethane- |
| diallyl nonanedioate |
| 3-(allyloxy)propyl methacrylate |
| 2,2-bis(bromomethyl)propane-1,3-diyl dia |
| but-2-ene-1,4-diyl bis(2-methylacrylate) |
| 2-((trimethylsilyl)oxy)propane-1,3-diyl |
| 1-[(2,4-Dibromo-5-thiazolyl)methyl]-1H-i |
| 5-[(2,4-Dibromo-5-thiazolyl)methyl]-1-me |
| 1H-Pyrazole-4-carboxaldehyde, 3-chloro-1 |
| Pyridine, 3-bromo-5-fluoro-2-(trimethyls |
| Isoxazole, 3-ethyl-5-[[(tetrahydro-2H-py |
| 2-(3-Chloro-1H-pyrazol-1-yl)-5-fluoroben |
| 4-Bromo-5-oxazolemethanol |
| 1-(Cyclopropylmethyl)-4-[(3-iodo-1-methy |
| (1-ethyl-1H-pyrazol-4-yl)(5-iodo-2-methy |
| 2-Bromo-4-fluorobenzamide |
| (1,1-Dimethylethyl)dimethyl(3-nitropropo |
| 1H-Pyrazole, 1-(2,2-difluoroethyl)-4-iod |
| 1-(2-bromo-4-fluorophenyl)prop-2-yn-1-ol |
| 1-(2,2-Difluoroethyl)-3-methyl-1H-pyrazo |
| 1-(2,2-Difluoroethyl)-1H-pyrazole-4-meth |
| Methyl 3-ethenyl-1-methyl-1H-pyrazole-5- |
| 5-(Cyclopropylmethyl)-1-methyl-1H-pyrazo |
| 1-Ethyl-4-iodo-3-methoxy-1H-pyrazole |
| 3,5-Difluoro-2-iodo-N-methoxy-N-methylbe |
| 1-(2,2-Difluoroethyl)-1H-pyrazole |
| 4-(Chloromethyl)-1-(2,2-difluoroethyl)-1 |
| 2-(2-Bromo-4-fluorophenyl)-1H-imidazole |
| 4-Fluoro-2-iodobenzoic acid hydrazide |
| Ethyl 5-bromo-1-(2,2-difluoroethyl)-1H-p |
| Methyl 5-bromo-1-ethyl-1H-pyrazole-4-ace |
| Ethyl 3-(2-bromo-4-fluorophenyl)-5-isoxa |
| 3-(Azidomethyl)-2-bromopyridine |
| 3-(2-Bromo-4-fluorophenyl)-4-isoxazoleca |
| 1-[(5-Bromo-4-thiazolyl)methyl]-1H-pyraz |
| 1H-Pyrazole, 5-bromo-3-methoxy-1-[[2-(tr |
| 1-(5-Fluoro-2-iodophenyl)-1,2-ethanediol |
| 3-Bromo-1-ethyl-4-iodo-1H-pyrazole |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| Rovathin619 | Calcium levofolinate | 80433-71-2 | EP |
| Rovathin620 | cisplatin | 15663-27-1 | USP |
| Rovathin621 | Cytarabine | 69-74-9 | USP |
| Rovathin622 | Docetaxel | 114977-28-5 | 98% |
| Rovathin623 | Etoposide | 33419-42-0 | USP |
| Rovathin624 | Gemcitabine hydrochloride | 122111-03-9 | USP28 |
| Rovathin625 | Imatinib | 220127-57-1 | |
| Rovathin626 | Irinotecan | 100286-90-6 | |
| Rovathin627 | Lentinan | 37339-90-5 | USP |
| Rovathin628 | Methotrexate | 59-05-2 | USP |
| Rovathin629 | oxaliplatin | 61825-94-3 | EP |
| Rovathin630 | Paclitaxel | 33069-62-4 | USP |
| Rovathin631 | Raltitrexed | 112887-68-0 | |
| Rovathin632 | Tegafur | 17902-23-7 | JP |
| Rovathin633 | Temozolomide | 85622-93-1 | USP |
| Rovathin634 | Topotecan | 123948-87-8 | |
| Rovathin635 | Vinblastine sulfate | 143-67-9 | USP |
| Rovathin636 | Zoledronic Acid | 118072-93-8 | EP |
| Rovathin637 | 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate | 122111-01-7 | 95% |
| Rovathin638 | Ethyl bromodifluoroacetate | 667-27-6 | |
| Rovathin639 | 4'-Demethylpodophyllotoxin | 40505-27-9 | 97% |
| Rovathin640 | Cytidine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate (9CI) | 134790-39-9 | 97% |
| Rovathin641 | D-erythro-Pentofuranose, 2-deoxy-2,2-difluoro-, 3,5-dibenzoate 1-methanesulfonate (9CI) | 122111-11-9 | 97% |
| Rovathin642 | D-erythro-Pentonic acid, 2-deoxy-2,2-difluoro-4,5-O-(1-methylethylidene)-, ethyl ester (9CI) | 95058-92-7 | 97% |
| Rovathin643 | 3-bromo-2-chloropyridine | 52200-48-3 | 97% |
| Rovathin644 | (R)-(-)-1-Benzyl-3-aminopyrrolidine | 114715-39-8 | 95% |
| Rovathin645 | (R)-(+)-1-Boc-3-aminopyrrolidine | 147081-49-0 | 95% |
| Rovathin646 | 6,12-Dibromochrysene | 131222-99-6 | 95% |
| Rovathin647 | Ethyl 4-fluorobenzoylacetate | 1999-00-4 | 95% |
| Rovathin648 | 4-Chloro-1H-pyrazolo[3,4-d]pyrimidine | 5399-92-8 | 95% |
|
|
|
|
